Professor Peter John Browett


Selected publications and creative works (Research Outputs)

  • Ameratunga, R., Koopmans, W., Woon, S.-T., Leung, E., Lehnert, K., Slade, C. A., ... Browett, P. (2017). Epistatic interactions between mutations of TACI (TNFRSF13B) andTCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus. Clinical & Translational Immunology, 6 (10)10.1038/cti.2017.41
    Other University of Auckland co-authors: Euphemia Leung, Klaus Lehnert
  • Quach, H., Fernyhough, L., Henderson, R., Corbett, G., Baker, B., Browett, P., ... Cannell, P. (2017). Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study. British Journal of Haematology, 177 (3), 441-448. 10.1111/bjh.14562
  • Hemmington, A., Dalbeth, N., Jarrett, P., Fraser, A. G., Broom, R., Browett, P., & Petrie, K. J. (2017). Medical specialists' attitudes to prescribing biosimilars. Pharmacoepidemiology and Drug Safety, 26 (5), 570-577. 10.1002/pds.4186
    Other University of Auckland co-authors: Alan Fraser, Nicola Dalbeth, Paul Jarrett, Keith Petrie
  • Harris, G., O'Toole S, George, P., Browett, P., & Print, C. (2017). Massive parallel sequencing of solid tumours - Challenges and opportunities for pathologists. Histopathology, 70 (1), 123-133. 10.1111/his.13067
    Other University of Auckland co-authors: Cristin Print
  • Quach, H., Harrison, S., Fernyhough, L. J., Henderson, R. A., Corbett, G., Browett, P., ... Trotman, J. (2015). Lower Dose Lenalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma Who Are Aged 60 Years or over and/or at Risk of Myelosuppression: Final Analysis of the Revlite Trial and Matched Comparison to the MM009 and MM010 Trials. Paper presented at 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL. 5 December - 8 December 2015. BLOOD. (pp. 2).
  • Fliegauf, M., Bryant, V. L., Frede, N., Slade, C., Woon, S. T., Lehnert, K., ... Leung, E. (2015). Haploinsufficiency of the NF-κB1 subunit p50 in common variable immunodeficiency. American Journal of Human Genetics, 97 (3), 389-403. 10.1016/j.ajhg.2015.07.008
    Other University of Auckland co-authors: Euphemia Leung, Klaus Lehnert, See-Tarn Woon
  • Iland, H. J., Collins, M., Bradstock, K., Supple, S. G., Catalano, A., Hertzberg, M., ... Campbell, L. J. (2015). Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial. Lancet Haematology, 2 (9), e357-e366. 10.1016/S2352-3026(15)00115-5
  • Kamal, T., Green, T. N., Morel-Kopp, M. C., Ward, C. M., McGregor, A. L., McGlashan, S. R., ... During, M. J. (2015). Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiation. Cellular Signalling, 27 (9), 1860-1872. 10.1016/j.cellsig.2015.05.004
    Other University of Auckland co-authors: Stefan Bohlander, Sue McGlashan, Maggie Kalev, Taryn Green

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 4, Room 403
New Zealand